Overview

Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome Patients

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacodynamic effect of ticagrelor in ACS patients undergoing an Ad Hoc PCI
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Clopidogrel
Ticagrelor
Ticlopidine